Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-definition/3d) was not found.

Search biology definition 3d at Google

Search biology definition 3d at Yahoo

Search biology definition 3d at Msn

Google
 
(Date:1/5/2009)...RK, NY (January 5, 2009) The copper industry is w...ion: Can copper and copper alloys (brass and bronz...pital infection? Results of laboratory testing and...s from around the world shared their work at the f...n copper,s role in fighting the bacteria that caus...
(Date:1/5/2009)...here is a threat of disease during pregnancy, moth...nt immune systems, researchers at The University o...es the first evidence for a transgenerational effe... with maternal perception of disease risk in the i...ring disease resistance and social dominance. The ...
(Date:1/5/2009)...Rochelle, NY, January 5, 2009Theodosius Dobzhansky...gist, said it best: "Nothing in biology makes sens... marks the 200th birthday of Charles Darwin (Febru...lication of the Origin of Species, which laid out ...ion in exquisite detail. Universities, academic ce...
(Date:1/5/2009)...of the current handicaps of cancer treatments is t...ying malignant cells without killing healthy cells...rsity researchers has provided insight into how sc...re carefully target cancer, while sparing normal h...of the McMaster Stem Cell and Cancer Research Inst...
Breaking Biology News(10 mins):International copper industry defines role in the fight against hospital infections 2Mothers pass on disease clues to offspring 2GEN joins Charles Darwin 2009 celebration 2Scientists can now differentiate between healthy cells and cancer cells 2Meniscal damage and joint malalignment predictors of cartilage loss 20897 1Meniscal damage and joint malalignment predictors of cartilage loss 20897 2Meniscal damage and joint malalignment predictors of cartilage loss 20897 3Katzen Eye Group Announces a New Option in Vision Correction Technology for Patients 20895 1Katzen Eye Group Announces a New Option in Vision Correction Technology for Patients 20895 2ALL vs NOW 3A Pill Protest Heating Up 20893 1ALL vs NOW 3A Pill Protest Heating Up 20893 2ALL vs NOW 3A Pill Protest Heating Up 20893 3Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 1Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 2Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 3Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 4
... researchers to pinpoint why only some parts of th...ofessor Peter Dodd and his team from UQ,s School o...ive-year, $1.23 million grant from the United Stat... of Health (NIH) to find out. , Chronic alcohol ... which affect planning, and social interactions an...
...vania School of Medicine have discovered that nerv...nger RNA (pre-mRNA), a process once believed to on...ring this capability in dendrites, the investigato...ning, as well as cognitive dysfunction. Senior aut..., and lead authors Kevin Miyashiro, and Jason Glan...
...rsial new study, Emily Oster (a graduate student i...ess female mortality, such as infanticide, may not...le ratios in many Asian countries. It has long bee...gher in certain Asian countries than in the West, ...ve suggested that this imbalance reflects neglect ...
... of York,s Department of Chemistry have developed ... unpleasant and dangerous side-effects of radiothe..., together with post-doctoral research fellow Mark...ctors to target cancer tumours more efficiently. ,...science Yorkshire Enterprise Fellowship scheme to ...
Other Biology News:Mapping alcohol brain damage 2RNA splicing occurs in nerve-cell dendrites 2RNA splicing occurs in nerve-cell dendrites 3Young scientists turn to gel to ease side-effects of cancer treatment 2
(Date:1/5/2009)... Industry expert and B2B Marketing Pro Toby Youni...uzzMaking: Socializing Your Way to Market Tangibil...executives in B2B companies facing challenging rev... Washington, DC (PRWEB) December... Toby Younis today announced a free webcast enti...
(Date:1/5/2009)...nflict, medical supplies remain most urgent need ,... -- The American Red Cross is contributing $250,00... Committee of the Red Cross (ICRC) to address the ...e Gaza Strip. , , "The American Red Cross cont...manitarian needs for medical support, hospital sup...
(Date:1/5/2009)...09 Forest Laboratories, ... and marketer of pharmaceutical products, will rel...ts before the U.S. stock market opens on Tuesday, ..., Forest will host a conference call where Dr. Law...er and Frank Perier, Senior Vice President-Finance...
(Date:1/5/2009)...d BCBSA Target April 2009 Interoperability Showcas...ect Demonstration , , WASHINGTON, Jan. 5 /PRNe...zations announced today they are collaborating wit...CMS) on the formation of a 5010 Testing Project to...10 transactions implementation. The organizations...
Breaking Medicine News(10 mins):Health News:B2B Marketing Pro Toby Younis Announces Free Webcast on "BuzzMaking" 2Health News:The American Red Cross Sends Aid as Humanitarian Situation Worsens in Gaza 2Health News:Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Third Quarter Earnings 2Health News:Healthcare Organizations Launch Collaborative Initiative to Test HIPAA Transactions Against Proposed 5010 Standards 2Health News:Healthcare Organizations Launch Collaborative Initiative to Test HIPAA Transactions Against Proposed 5010 Standards 3Health News:Healthcare Organizations Launch Collaborative Initiative to Test HIPAA Transactions Against Proposed 5010 Standards 4Health News:Healthcare Organizations Launch Collaborative Initiative to Test HIPAA Transactions Against Proposed 5010 Standards 5
...rding to a new enzyme which is discovered, may int...ently from other painkillers. //Acetaminophen (par...ever, but not inflammation. Whereas aspirin and ib...non-steroidal anti-inflammatory agents (NSAIDs). T...
...ession, irritability and dullness are common among...in from prompt treatment.// The Cardiovascular Hea...eart disease and stroke in those over 60. It invol...e of who had a MRI scan which could indicate mild ...
...rding to a new study, researchers found that the t...a 'Mediterranean' pattern of alcohol abuse. Resear... drinking// - the Anglo-Saxon/Scandinavian pattern...the weekend and holidays, and the Mediterranean pa...
...rding to researchers from the University of Califo... who use estrogen are at a higher risk for develop...nge in the joints that causes pain in that area.//...of adults over 40 years old. Experts estimate up t...
Other Medicine News:
These Costar 96-well, flat-bottom polystyrene EIA plates are used for EIAs, ELISAs, and other protein binding assays. Supplied as box of 100 (20 packages; 5 plates per package).
The Chemicon Detergent-OUT Kit is a simple high performance method for removing detergents from protein solutions. Removes detergents without significant dilution of protein solution. Simply load t
...emicon Detergent-OUT Kit is a simple high performa...lutions. Removes detergents without significant d...ein solution on the Detergent-OUT Spin column and ...column is suitable for removing detergents from a ...
... tissue microarrays are derived from frozen embedd...quality control procedures to ensure the highest q...ed in one block, sectioned at a thickness of 7 mic...rge (3-5 mm in diameter) in comparison to core sec...
Biology Products:
... American standard, corrected curve trial lenses a...ed in Marco refractors and are invaluable in treat...ets of other manufacturers contain a disproportion...which are less expensive to produce, and fewer len...
The LM-990A is the most completely automatic lensemeter ever created. It even measured monocular and binocular PD automatically.
simplified focusing guidance system has made the LM-770 the easiest instrument to use of its type. Technicians can be trained to operate the LM-770 with a minimum of instruction. The instrument tells
The digital EPIC is designed to perform precise and accurate refractions in half the time and one-third the space of traditional examinations. By integrating electronically with Marco Technologies re
Medicine Products:
(Date:1/5/2009)...ire/ -- In their latest book, You: Being,Beautifu...Free Press, 2008),co-authors Mehmet Oz, MD and M...ecade,s "real nutritional heroes" that can "turbo-...s a naturally occurring 5-carbon sugar the body us...osphate (ATP) -- an essential,energy compound. ,...
(Date:1/5/2009)...wire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (N...ment will present a corporate overview at the upco...n Wednesday, January 14, 2009 at 7:30 a.m. PT at t..., The live and archived webcast of the company pr...ts" in the Idenix Investor Center at www.idenix.c...
(Date:1/5/2009)...5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Cor..."Company"), today announced,that Sunstone (Tangsh...h tech,status in China,s Hebei province. High te...anies that consistently invest in new product deve...y their own proprietary patented or,innovative pr...
(Date:1/3/2009)...Norton, MBA, PE, President of Norton & Associa...and Carbon Technology Management with the Carbon C...ding corporation, US Property Portfolio, private...ng for liquidated failed commercial properties. Wi...n & Associates Inc. provides P & L Managem...
Breaking Biology Technology:You: Being Beautiful Authors Mehmet Oz, MD, & Michael Roizen, MD, Call Ribose One of the Decade's 'Real Nutritional Heroes' 2You: Being Beautiful Authors Mehmet Oz, MD, & Michael Roizen, MD, Call Ribose One of the Decade's 'Real Nutritional Heroes' 3BMP Sunstone Receives High Tech Status 2BMP Sunstone Receives High Tech Status 3Norton & Associates Inc. Adds $3bnUSD Commercial Real Estate Investment P & L Management Holding Group; US Property Portfolio Inc. 2
... , , , , Multiporator / Electrop..., , , Transformation ...01/2002 , , , , , , ... Microorganism , Staphylococcus ...pe , Bacteria, gram positive, ...
... , , , , Multiporator , , ..., Transfection Protocol , P... , , , , , , , ,... RAW 264.7 mouse macrophages, , ... Plasmid pEGFP-N1 (in bidistilled H 2 O), ...
... , , , , Multiporator / Electrop..., , , Transformation ...01/2002 , , , , , , ... Microorganism , Pseudomonas aer...ype , Bacteria, gram negative, ...
... , , , , Multiporator , , ..., Transformation Protocol , ... , , , , , , , ... Neurospora crassa, , ,...gus, protoplasts, , , ...
Other Biology Technology:Staphylococcus aureus 2RAW 264.7 2Pseudomonas aeruginosa 2Neurospora crassa 2
(Date:12/17/2008)... Calif., Dec. 17 PEAK Surgical, In... new tissue dissection system based on a,propriet... and Drug,Administration (FDA) has granted the co...ery System for cutting and coagulation of soft tis...nose and throat), gynecologic,orthopedic, arthro...
(Date:12/17/2008)... ANTIPOLIS, France, December 17 /PRNewswire-FirstC...ay announced positive results of a,pre-specified ...tis (OA) from,the 301, 302 and 303 pivotal phase ...nod showed a significant reduction in systolic and...to naproxen 500 mg bid over the whole 13 week,per...
(Date:12/16/2008)...ncovers New Link Between Inflammation & Alzhei...PRNewswire/ -- The Roskamp Institute today announc...between inflammation and Alzheimer,s disease and h...ovel therapeutics for intervention in this disease...akshi, Ph.D., is detailed in the American Chemica...
(Date:12/16/2008)...herapeutics Technology Provided CML Biomarker Data...RNewswire-FirstCall/ -- Synvista Therapeutics, In...wo publications demonstrating findings from studie... glycation end product (A.G.E.) called carboxymeth... a decline in renal function and arterial stiffnes...
Breaking Medicine Technology:PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 2NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 3NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 4NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 5Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 2Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 3Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 2Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 3Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 4Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 5Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress 5744 1Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress 5744 2Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 1Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 2Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 3Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 4Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 5Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 6Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 7Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 8Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine 28R 29 28VNP40101M 29 in Acute Myelogenous Leu 2292 1Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine 28R 29 28VNP40101M 29 in Acute Myelogenous Leu 2292 2Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine 28R 29 28VNP40101M 29 in Acute Myelogenous Leu 2292 3Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine 28R 29 28VNP40101M 29 in Acute Myelogenous Leu 2292 4Drug May Cut Tremors Associated With Parkinsons 20889 1Drug May Cut Tremors Associated With Parkinsons 20889 2
...S, Calif., June 05, 2007 /PRNewswire-FirstCall/ --...ata from a,preclinical study of novel monoclonal a...The data demonstrate that NTB-A is a,potential new...ncluding leukemia and lymphomas. The study, entitl...vel monoclonal antibody target for,leukemia and ly...
...cation highlights health care cost benefit of,bioe...ewswire-FirstCall/ -- Cell,Therapeutics, Inc. (CTI... Meeting of the American Society of Clinical Oncol...ce utilization (MRU) and,associated costs with XYO...gemcitabine or vinorelbine in treating patients wi...
Other Medicine Technology:Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 2Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 3Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 4XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine,or Vinorelbine in Treating Non-Small Cell Lung Cancer 2XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine,or Vinorelbine in Treating Non-Small Cell Lung Cancer 3XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine,or Vinorelbine in Treating Non-Small Cell Lung Cancer 4